Vitrase FDA Approval History
FDA Approved: Yes (First approved May 5, 2004)
Brand name: Vitrase
Generic name: hyaluronidase
Dosage form: for Injection
Company: ISTA Pharmaceuticals, Inc.
Treatment for: Hypodermoclysis, Subcutaneous Urography
Vitrase is a preparation of purified ovine testicular hyaluronidase indicated as an adjuvant to increase the absorption and dispersion of other injected drugs; for hypodermoclysis; and as an adjunct in subcutaneous urography for improving resorption of radiopaque agents.
Development timeline for Vitrase
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.